Peripheral cocaine-blocking agents: new medications for cocaine dependence. An introduction to immunological and enzymatic approaches to treating cocaine dependence reported by Fox, Gorelick and Cohen in the immediately succeeding articles (see pages 153-174).
Sparenborg
S
S
Medications Development Division, National Institute on Drug Abuse, National Institutes of Health, Rockville, MD 20857, USA. ss292q@nih.gov
Vocci
F
F
Zukin
S
S
D017151:Antibodies, Catalytic / Q000627:therapeutic use; D016739:Behavior, Addictive / Q000188:drug therapy; D001812:Blood-Brain Barrier; D002091:Butyrylcholinesterase / Q000627:therapeutic use; D003042:Cocaine / Q000037:antagonists & inhibitors / Q000276:immunology / Q000493:pharmacokinetics; D019970:Cocaine-Related Disorders / Q000188:drug therapy* / Q000201:enzymology / Q000276:immunology; D006801:Humans; D014612:Vaccines / Q000627:therapeutic use*
D017151:Antibodies, Catalytic; D014612:Vaccines; D002091:Butyrylcholinesterase; D003042:Cocaine